A detailed history of Pnc Financial Services Group, Inc. transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 29 shares of GLSI stock, worth $243. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29
Holding current value
$243
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$9.24 - $12.49 $267 - $362
29 New
29 $0
Q3 2021

Nov 05, 2021

SELL
$38.65 - $46.11 $3,865 - $4,611
-100 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$31.24 - $53.6 $3,124 - $5,360
100 New
100 $4,000

Others Institutions Holding GLSI

About Greenwich LifeSciences, Inc.


  • Ticker GLSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,848,200
  • Market Cap $108M
  • Description
  • Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...
More about GLSI
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.